News & Updates
Filter by Specialty:
COVID-19 vacc side effects: Fewer than expected?
A community-based study from the UK showed that the rate of systemic side effects is relatively low following vaccination with the BNT162b2 or ChAdOx1 nCoV-19 COVID-19 vaccines.
COVID-19 vacc side effects: Fewer than expected?
01 Oct 2021Major infections after PCI, CABG do not affect very long-term survival
While major infections worsen 5-year survival after percutaneous coronary intervention (PCI) or coronary artery bypass graft (CABG) for coronary artery disease, no detrimental effects on mortality are observed thereafter, suggesting that its impact subsides after 5 years, a recent study has found.
Major infections after PCI, CABG do not affect very long-term survival
01 Oct 2021Pimavanserin for dementia-related psychosis: to continue or not?
In individuals with dementia-related psychosis (DRP) who had a response to the oral 5-HT2A* inverse agonist and antagonist pimavanserin, an atypical antipsychotic agent, the risk of relapse was lower among those who continued the drug vs those who stopped it, the phase III HARMONY trial suggests.
Pimavanserin for dementia-related psychosis: to continue or not?
01 Oct 2021Severe hypoglycaemia ups risk of adverse outcomes in older patients
Severe hypoglycaemia is a risk factor for hospitalization and mortality among older patients with diabetes, a study reports. The event may also serve as a marker of future cardiovascular events among those with pre-existing heart disease and obesity.
Severe hypoglycaemia ups risk of adverse outcomes in older patients
01 Oct 2021VO2 improvements after cardiac rehabilitation tied to better outcomes in high-risk HF
Higher-risk heart failure (HF) patients who show improvements in peak oxygen consumption (VO2) following cardiac rehabilitation (CR) have lower risks of new-onset atrial arrhythmias, mortality, and hospitalization due to HF exacerbation, a recent study has found.